January 31 - February 3, 2007
Pointe Hilton Tapatio Cliffs Resort
Phoenix, Arizona
CONFERENCE CHAIRPERSONS:
Jeffrey M. Trent, Translational Genomics Research Institute, Phoenix, AZ
Nicholas C. Dracopoli, Bristol-Myers Squibb Company, Princeton, NJ
Laura J. van’t Veer, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Nearly 300 scientists from academia, government, and industry gathered outside Phoenix for the fifth AACR Oncogenomics conference. Bringing together a diverse group of scientists working in the fields of genome research and cancer biology, this conference explored how genomic research can be used most effectively to impact the clinical response to cancer.
The conference began on Wednesday, January 31, with an extended session on Regulatory Perspectives on Biomarker/Devive and New Drug Development in Oncology that included invited talks as well as panel discussions. Session topics addressed included Statistical Considerations of High Content Data; Clinical Genomics; Genomic, Functional, and Chemoinformatic Strategies for New Cancer Drug Development; Functional Genomics: RNAi and Beyond; Advances in Genomic Technologies; the Human Cancer Atlas Project; and Cancer Genetics and Whole Genome Scanning. The conference concluded on Saturday, February 3, with a Bioinformatics Workshop. Over 100 posters were presented from submitted abstracts.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.